Source:http://linkedlifedata.com/resource/pubmed/id/16920940
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2006-8-21
|
pubmed:abstractText |
Chronic malaria infection is characterized by polyclonal B cell activation, hyperglobulinemia, and elevated titers of autoantibodies. We have recently identified the cysteine-rich interdomain region 1alpha (CIDR1alpha) of the Plasmodium falciparum erythrocyte membrane protein 1 as a T cell-independent polyclonal B cell activator and Ig binding protein. Here, we show that, although the binding affinity of CIDR1alpha to human IgM and IgG is relatively low, B cell activation still proceeds. CIDR1alpha rescues tonsillar B cells from apoptosis, and increases the proportion of cycling cells. Comparison of the impact on naive and memory B cell compartment indicated that CIDR1alpha preferentially activates memory B lymphocytes. Analysis of the gene expression profiles induced by CIDR1alpha and anti-Ig activation using a cDNA microarray demonstrated a low degree of homology in the signatures imposed by both stimuli. The microarray data correlate with the functional analysis demonstrating that CIDR1alpha activates various immunological pathways and protects B cells from apoptosis. Together, the results provide evidence for a role of malaria in preferentially activating the memory B cell compartment. The polyclonal B cell activation and augmented survival induced by CIDR1alpha is of relevance for understanding the mechanisms behind the increased risk of Burkitt's lymphoma in malaria endemic areas.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/Protozoan Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/erythrocyte membrane protein 1...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
177
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3035-44
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16920940-Animals,
pubmed-meshheading:16920940-Antibodies,
pubmed-meshheading:16920940-B-Lymphocytes,
pubmed-meshheading:16920940-Cell Survival,
pubmed-meshheading:16920940-Cells, Cultured,
pubmed-meshheading:16920940-Gene Expression Profiling,
pubmed-meshheading:16920940-Gene Expression Regulation,
pubmed-meshheading:16920940-Humans,
pubmed-meshheading:16920940-Immunologic Memory,
pubmed-meshheading:16920940-Lymphocyte Activation,
pubmed-meshheading:16920940-Malaria,
pubmed-meshheading:16920940-Phenotype,
pubmed-meshheading:16920940-Plasmodium falciparum,
pubmed-meshheading:16920940-Protein Binding,
pubmed-meshheading:16920940-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:16920940-Protozoan Proteins
|
pubmed:year |
2006
|
pubmed:articleTitle |
Increased B cell survival and preferential activation of the memory compartment by a malaria polyclonal B cell activator.
|
pubmed:affiliation |
Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden. daria.donati@ki.se
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|